Legacy Wealth Management (Idaho)’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-85
Closed -$1.44K 791
2025
Q1
$1.44K Hold
85
﹤0.01% 590
2024
Q4
$1.37K Hold
85
﹤0.01% 556
2024
Q3
$1.57K Buy
+85
New +$1.9K ﹤0.01% 502

Other funds holding FLGT

Legacy Wealth Management (Idaho)'s FLGT Position: Q2 2025 in Review

Legacy Wealth Management (Idaho) sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 85 shares — an estimated $1.44K sold.

Legacy Wealth Management (Idaho) first reported a position in FLGT in Q3 2024 and held it in 3 quarters. The position peaked at $1.57K in Q3 2024. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Legacy Wealth Management (Idaho) reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 85 Fulgent Genetics shares in Q2 2025, an estimated $1.44K.
  • Legacy Wealth Management (Idaho) first reported a position in Fulgent Genetics in Q3 2024 and held it in 3 quarters.
  • Legacy Wealth Management (Idaho)'s Fulgent Genetics position peaked at $1.57K in Q3 2024.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2025, filed 6 Aug 2025.